[1] Lee CH, Lee SW, Park SW. Diabetes and Subclinical Coronary Atherosclerosis. Diabetes Metab J. 2018;42(5):355‐363.
[2] Lehmann N, Erbel R, Mahabadi AA, Rauwolf M, Möhlenkamp S, Moebus S, et al. Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events: Result of the HNR Study (Heinz Nixdorf Recall). Circulation. 2018;137(7):665‐679.
[3] Osawa K, Nakanishi R, Budoff M. Coronary Artery Calcification. Glob Heart. 2016;11(3):287–293.
[4] Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011;17(11):1410‐1422. Published 2011 Nov 7.
[5] Emamalipour M, Seidi K, Jahanban-Esfahlan A, Jahanban-Esfahlan R. Implications of resistin in type 2 diabetes mellitus and coronary artery disease: Impairing insulin function and inducing pro-inflammatory cytokines. J Cell Physiol. 2019;234(12):21758‐21769.
[6] Cai G, Liu W, Lv S, Wang X, Guo Y, Yan Z, et al. Gender-specific associations between atherogenic index of plasma and the presence and severity of acute coronary syndrome in very young adults: a hospital based observational study[J]. Lipids Health Dis, 2019, 18(1):99.
[7] Alizargar J, Bai CH, Hsieh NC, Wu SV. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients[J]. Cardiovasc Diabetol, 2020, 19(1):8.
[8] Xiang F, Chen R, Cao X, Shen B, Liu Z, Tan X, et al. Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: A prospective cohort study. Hemodialysis international International Symposium on Home Hemodialysis, 2018;22(1):82-92.
[9] Meeuwsen JAL, de Vries J, Zoet GA, Franx A, Fauser BCJM, Maas AHEM, et al. Circulating Neutrophils Do Not Predict Subclinical Coronary Artery Disease in Women with Former Preeclampsia. Cells. 2020;9(2):468. Published 2020 Feb 18.
[10] Stein R, Ferrari F, Scolari F. Genetics, Dyslipidemia, and Cardiovascular Disease: New Insights. Curr Cardiol Rep. 2019;21(8):68. Published 2019 Jun 21. .
[11] Vancheri F, Longo G, Vancheri S, Danial JSH, Henein MY. Coronary Artery Microcalcification: Imaging and Clinical Implications. Diagnostics (Basel). 2019;9(4):125. Published 2019 Sep 23.
[12] Shaikh K, Nakanishi R, Kim N, Budoff MJ. Coronary artery calcification and ethnicity. J Cardiovasc Comput Tomogr. 2019;13(6):353–359.
[13] Lu H, Daugherty A. Atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35(3):485-91
[14] Peng J, Luo F, Ruan G, Peng R, Li X. Hypertriglyceridemia and atherosclerosis. Lipids Health Dis. 2017;16(1):233. Published 2017 Dec 6.
[15] Di Pino A, DeFronzo RA. Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents. Endocr Rev. 2019;40(6):1447–1467.
[16] Farmer JA, Gotto AM Jr. Dyslipidemia and the vulnerable plaque. Prog Cardiovasc Dis. 2002;44(6):415‐428.
[17] Wu TT, Gao Y, Zheng YY, Ma YT, Xie X. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis. 2018;17(1):197.
[18] Guo Q, Zhou S, Feng X, Yang J, Qiao J, Zhao Y, et al. The sensibility
of the new blood lipid indicator--atherogenic index of plasma (AIP) in menopausal women with coronary artery disease. Lipids Health Dis. 2020 Feb 24;19(1):27.
[19] Cure E, Cumhur Cure M. Comment on "The relationship between atherogenic index of plasma and no‑reflow in patients with acute ST‑segment elevation myocardial infarction who underwent primary percutaneous coronary intervention". Int J Cardiovasc Imaging. 2020;36(5):797‐798.
[20] Cai G, Shi G, Xue S, Lu W. The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population. Medicine (Baltimore). 2017;96(37):e8058.
[21] Cho YR, Ann SH, Won KB, Park GM, Kim YG, Yang DH, et al. Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes. Sci Rep. 2019 Sep 2;9(1):6129.
[22] da Silva A, Caldas APS, Hermsdorff HHM, Bersch-Ferreira ÂC, Torreglosa CR, Weber B, et al. Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovasc Diabetol. 2019;18(1):89. Published 2019 Jul 11.
[23] Jin JL, Cao YX, Wu LG, You XD, Guo YL, Wu NQ, et al. Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease. J Thorac Dis. 2018;10(11):6137‐6146.
[24] Won KB, Kim YS, Lee BK, Heo R, Han D, Lee JH, et al. The relationship of insulin resistance estimated by triglyceride glucose index and coronary plaque characteristics. Medicine (Baltimore). 2018;97(21):e10726.
[25] Novo G, Manno G, Russo R, Buccheri D, Dell'Oglio S, Morreale P, et al. Impact of insulin resistance on cardiac and vascular function. Int J Cardiol. 2016;221:1095‐1099.
[26] Montecucco F, Steffens S, Mach F. Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability. Mediators Inflamm. 2008;2008:767623.
[27] Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018 Aug 31;17(1):122.
[28] Wen Y, Zhan X, Wang N, Peng F, Feng X, Wu X. Monocyte/Lymphocyte Ratio and Cardiovascular Disease Mortality in Peritoneal Dialysis Patients. Mediators Inflamm. 2020;2020:9852507.
[29] Gijsberts CM, Ellenbroek GHJM, Ten Berg MJ, Huisman A, van Solinge WW, Lam CS, et al. Effect of Monocyte-to-Lymphocyte Ratio on Heart Failure Characteristics and Hospitalizations in a Coronary Angiography Cohort. Am J Cardiol. 2017;120(6):911‐916.
[30] Fan Z, Ji H, Li Y, Jian X, Li L, Liu T. Relationship between
monocyte-to-lymphocyte ratio and coronary plaque vulnerability in patients with stable angina. Biomark Med. 2017;11(11):979‐990.
[31] Shaw DM, Merien F, Braakhuis A, Dulson D. T-cells and their cytokine production: The anti-inflammatory and immunosuppressive effects of strenuous exercise. Cytokine. 2018;104:136-142.
[32] Register TC, Appt SE, Clarkson TB. Atherosclerosis and Vascular Biologic Responses to Estrogens: Histologic, Immunohistochemical, Biochemical, and Molecular Methods. Methods in molecular biology (Clifton, NJ). 2016;1366:517-532.